phosphoserine has been researched along with Lupus Erythematosus, Systemic in 2 studies
Phosphoserine: The phosphoric acid ester of serine.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monneaux, F | 1 |
| Muller, S | 1 |
| Utz, PJ | 1 |
| Hottelet, M | 1 |
| Schur, PH | 1 |
| Anderson, P | 1 |
2 other studies available for phosphoserine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
[The spliceosome and its interest for lupus therapy].
Topics: Amino Acid Motifs; Animals; Antibodies; CD4-Positive T-Lymphocytes; Conserved Sequence; DNA, Recombi | 2007 |
Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus.
Topics: Apoptosis; Autoantibodies; Autoantigens; Cells, Cultured; DNA Fragmentation; fas Receptor; Humans; L | 1997 |